Reducing Risk of Recurrent Cystitis
Prevention Strategies
- The American Urological Association recommends vaginal estrogen replacement as the foundation of prevention for postmenopausal women, reducing recurrence by 75% 1
- The European Urology association suggests that premenopausal women use post-coital or continuous low-dose antibiotic prophylaxis when behavioral modifications fail 1
Algorithmic Approach by Patient Population
- For postmenopausal women, vaginal estrogen is the most effective non-antimicrobial intervention with strong evidence, reducing recurrent UTIs by 75% 1
- The European Urology association recommends methenamine hippurate 1 gram twice daily for women without urinary tract abnormalities 3, 2, 1
Non-Antimicrobial Alternatives
- Methenamine hippurate 1 gram twice daily is strongly recommended for women without urinary tract abnormalities, with a relative risk of 0.24 in patients without renal tract abnormalities 3, 2, 1, 5
- Immunoactive prophylaxis (OM-89/Uro-Vaxom) is strongly recommended to reduce recurrent UTI in all age groups 3, 1
Antibiotic Prophylaxis Regimens
- Continuous or postcoital antimicrobial prophylaxis should be used when non-antimicrobial interventions have failed, with nitrofurantoin 50-100 mg daily preferred due to low resistance rates 3, 2
- Trimethoprim-sulfamethoxazole 160/800 mg daily is an alternative option for continuous daily prophylaxis 5
Diagnostic Confirmation Requirements
- Diagnose recurrent UTI via urine culture, with documentation of positive urine cultures associated with each symptomatic episode to confirm the diagnosis 3, 2, 6
Critical Pitfalls to Avoid
- Do not treat asymptomatic bacteriuria, which increases antimicrobial resistance without improving outcomes 2, 5
- Do not use broad-spectrum antibiotics when narrower options are available, and avoid prolonged antibiotic courses (more than 5 days) or unnecessary antibiotics 2, 5, 6